Episode Details
Back to Episodes
Prompter Scandal Sparks Trading Debate, Bridge Collapse Trial Verdict, Merck Wins FDA Lipfendra Approval, Nadezhdin Convicted Barred, and more...
Published 1 month, 2 weeks ago
Description
(0:10): White House Teleprompter Scandal: Insider Trading Allegations Spark Regulatory Debate on Prediction Markets
(1:45): Morandi Bridge Collapse Trial: Former CEO Sentenced, Victims' Families Seek Justice in Genoa Verdict
(3:21): FDA Approves Merck's Lipfendra, First Cholesterol-Lowering Pill, Offering Hope for High-Risk Patients
(5:16): Russian Opposition Leader Boris Nadezhdin Convicted, Barred from Parliamentary Race
(6:45): EU Court Ruling Limits Platform Immunity, Holds YouTube Liable for Gambling Ad Content
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Local News Live
(1:45): Morandi Bridge Collapse Trial: Former CEO Sentenced, Victims' Families Seek Justice in Genoa Verdict
(3:21): FDA Approves Merck's Lipfendra, First Cholesterol-Lowering Pill, Offering Hope for High-Risk Patients
(5:16): Russian Opposition Leader Boris Nadezhdin Convicted, Barred from Parliamentary Race
(6:45): EU Court Ruling Limits Platform Immunity, Holds YouTube Liable for Gambling Ad Content
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Local News Live